Annals of neurology
From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple Sclerosis.
Laura Ghezzi, Peter Kosa, Mark Greenwood, Enrique Alvarez, C L Freedman, Anne H Cross, Francesca Pace, Mark S Freedman, Joanna Kocot, Laura Piccio, Bibiana Bielekova
Published: 202510.1002/ana.78047
Abstract
OBJECTIVE: The growing demand for personalized treatment in multiple sclerosis (MS) highlights the need for more precise biomarkers that can outperform magnetic resonance imaging and clinical assessment in patient stratification. Advances in multiple…
Preview only. Read the full abstract at the source